The Latin America, Middle East and Africa Recombinant Proteins Market would witness market growth of 14.0% CAGR during the forecast period (2022-2028).
The desire for novel, tailored medications, rise in cancer patients, and other industrial requirements like detergent and diagnostics are all projected to contribute to the total recombinant protein market experiencing considerable growth throughout the forecast period. In addition, subsequent generations of recombinant proteins made some advancements over the prior generation.
The second generation of recombinant proteins included proteins with improved qualities including selectivity, biodistribution, and efficacy, similar to the first generation, which included native protein structures. The third generation of recombinant proteins also included new formulations and administration methods with improved efficacy and security. Therefore, product innovation is the main driver of the recombinant protein market's expansion.
The United Arab Emirates has transformed into a prosperous, modern nation with a Western way of life from a developing nation with a sizable nomadic population. Certainly, this economic development has given UAE inhabitants social benefits and possibilities, including a high and rising life expectancy. But, a serious issue with chronic diseases, notably cardiovascular risk associated with obesity, has been exacerbated by fast industrialization and urbanization.
The Brazil market dominated the LAMEA Recombinant Proteins Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $45.3 million by 2028. The Argentina market is experiencing a CAGR of 14.6% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 13.6% during (2022 - 2028).
Based on Product, the market is segmented into Growth Factors & Chemokines, Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors, Structural Proteins, Membrane Proteins, Kinase Proteins & Regulatory Proteins, Immune Response Proteins, and Others. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Others. Based on Application, the market is segmented into Drug Discovery & Development, Academic Research Studies, Biopharmaceutical Production, Diagnostics, Biotechnology Research, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Recombinant Proteins Market is Predict to reach $2.6 Billion by 2028, at a CAGR of 10.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Techne Corporation, Thermo Fisher Scientific, Inc., Merck Group, Bio-Rad Laboratories, Inc., Abcam plc, Genscript Biotech Corporation, Miltenyi Biotec B.V. & Co. KG, Proteintech Group, Inc., BPS Bioscience, Inc., and RayBiotech Life, Inc.
By Product
By End User
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
